ライフサイエンスコーパス: we describe

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します

1 We describe a novel method of kinetic analysis of radioligand

2 We describe an intriguing tension between phenotypic complexi

3 We describe here a serum-free, artificial thymic organoid (AT

4 We describe here important differences in how the Rb and p107

5 We describe herein its structure and replicative cycle, along

6 We describe new mechanisms of coding and noncoding alteration

7 We describe opportunities and challenges in RNA structural mo

8 We describe the effect of varying particle size and shape on

9 We describe the structure and morphology of aggregates formed

10 We describe this method using dulaglutide, a glucagon-like pe

11 We describe two new complementary approaches - stable isotope

12 Using computational analysis, we describe the structural and photophysical properties of th

13 paper of the Series on health, equity, and women's cancers, we describe the burden of breast and cervical cancer, with an

14 To improve computational efficiency, we describe an new importance sampling scheme to perform mode

15 As an example, we describe how this method can be used to covalently immobil

16 Finally, we describe a novel form of activity-dependent intrinsic plas

17 Here we describe a molecular system that can be programmed to cont

18 Here we describe a new, exquisitely three-dimensionally preserved

19 Here we describe an enhanced fluorescence fluctuation imaging anal

20 Here we describe an update of the database.

21 Here we describe DeActs, genetically encoded actin-modifying polyp

22 Here we describe ShootingStar, a platform for perturbation analysi

23 Here we describe the 'Asgard' superphylum, a group of uncultivated

24 Here we describe the stabilization of the heaviest 4+ ion of the p

25 Here we described and analyzed a similar phenotype in POMT mutant

26 Here, we describe a combined biological/enzymatic synthesis that is

27 Here, we describe a generalizable platform to create dual-FP biosen

28 Here, we describe a mouse strain lacking the E3 ubiquitin ligase RN

29 Here, we describe a rapid, inexpensive, and portable strategy to ro

30 Here, we describe a structure we refer to as the embryo sheath that

31 Here, we describe how F-specific antibodies protect against RSV and

32 Here, we describe mGluR5 findings in stress disorders, particularly

33 Here, we describe site-selective, copper-promoted couplings of boro

34 Here, we describe the FEP+ method as applied to protein stability c

35 Here, we describe two brothers with hematopoietic and immunologic s

36 Herein, we describe a simple, selective, and mild procedure for the c

37 Lastly, we describe an analogous Foxa2+ population during differentia

38 Here, using a palette of histological methods we describe neurons and their neuropils most immediately asso

39 In this paper we describe HistomicsML, an interactive machine-learning syst

40 In this report we describe the appearance of transgene-specific T-cell respo

41 In this first part of a 2-part review, we describe indications, implant-related complications, basic

42 In this review, we describe speculative ideas and early stage research concer

43 In the present study, we describe for the first time the presence of ACSL6 mRNA in

44 In this study, we describe and characterize novel sensors based on the Syste

45 In this study, we describe data indicating that the yeast family members Ltc

46 In this study, we describe population-level trends in the adult life expecta

47 In summary, we describe a mechanism by which increased cytosolic Ca(2+) n

48 ured in any system through mechanisms similar to those that we describe here.

49 In this update, we describe recent changes and additions to our website, data

50 In this work, we describe an electronics-based Enzyme-Linked ImmunoSorbent

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。